Figure 2

Diminished levels of nasal S100A7 in allergic patients. (A) Baseline levels of S100A7 were measured by ELISA in nasal lavage (NAL) fluids obtained from healthy subjects (n = 13) and patients with seasonal allergic rhinitis (SAR, n = 12). **, p < 0.01 (unpaired t-test). (B) Levels of S100A7 in NAL fluid from patients with SAR before and 6 h after allergen provocation (n = 12). ***, p < 0.001 (paired t-test). (C) Baseline levels of S100A7 in NAL fluid obtained from patients with SAR before and 3 years after allergen-specific immunotherapy (ASIT, n = 10). *, p < 0.05 (paired t-test).